Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Synta Pharmaceuticals Corp (NASDAQ:SNTA)

2.12
Delayed Data
As of Jul 31
 +0.02 / +0.95%
Today’s Change
1.85
Today|||52-Week Range
4.19
-20.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
AssetsCash96.8M68.5M45.0M33.3M
 
 
 
 
 
Short Term Investment Cash44.8M-28.3M-22.5M-12.8M
 
 
 
 
 
Cash & Short Term Investments112.1M119.3M97.7M76.6M
 
 
 
 
 
 
ReceivablesReceivables0.000.00--0.00--
 
InventoriesInventories----------
 
Current AssetsOther Current Assets2.3M2.9M1.7M1.4M
 
 
 
 
 
Current Assets114.3M122.2M99.3M78.0M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross21.9M21.4M21.5M21.5M
 
 
 
 
 
Depreciation-20.6M-20.3M-20.5M-20.7M
 
 
 
 
 
Other Assets358.0K331.0K305.0K564.0K
 
 
 
 
 
Total Assets115.9M123.7M100.7M79.4M
 
 
 
 
 
 
LiabilitiesAccounts Payable5.2M4.4M3.1M0.00
 
 
 
 
Short Term Debt9.2M9.2M9.3M9.3M
 
 
 
 
 
Accrued Expenses15.5M16.5M14.6M15.3M
 
 
 
 
 
Other Current Liabilities15.5M16.5M14.6M19.1M
 
 
 
 
 
Other Liabilities32.7M33.0M30.9M30.9M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt9.3M7.0M4.7M2.3M
 
 
 
 
 
Total Liabilities41.9M39.9M35.5M33.3M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity74.0M83.7M65.1M46.1M
 
 
 
 
 
Total Shareholder Equity74.0M83.7M65.1M46.1M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding101.3M108.9M109.1M109.1M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.